Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Products & Services

TITLE:

MoH Order amending and supplementing Annex no. 1 to the MoH Order and NHIH Order 1301/ 500/2008 for the approval of therapeutic protocols for the prescription of medicinal products for the INNs listed in the List of INNs corresponding to the medicines received by insured persons, with or without personal contribution, on medical prescription, in the social health insurance system, as approved by the GD 720/2008

BRIEF:

This draft Order 1301/500/2008, introduces 2 new molecules (Trastuzumab and Osimertinib) and modifies 4 protocols (Viral chronic hepatitis and hepatic cirrhosis in HBV, Paliperidone, Trastuzumab, Osimertinib)

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company